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Abstract Glycemia and insulin resistance are impor-
tant regulators of multiple physiological processes and
their dysregulation has wide-ranging consequences,
including alterations in plasma concentrations of metal
micronutrients. Here, magnesium, zinc, copper, sele-
nium and glycated albumin (HbA1c) concentrations
and quartile differences were examined in 45 subjects
with type-I diabetes (T1DM), 54 subjects with type-II
diabetes (T2DM) and 62 control subjects in order to
assess potential differences between sexes and
between T1DM and T2DM. Plasma magnesium con-
centration was decreased in T1DM subjects, with the
second, third and fourth quartiles of magnesium
concentrations associated with the absence of T1DM.
This effect was observed in females but not males. In
T2DM, the highest quartile of selenium concentrations
and the third quartile of copper concentrations
associated with the absence of diabetes in males. The
highest quartile of magnesium concentrations was
associated with the absence of T2DM in males but not
females. HbA1c correlatedwith plasma concentrations
of magnesium (negatively, in both sexes together in
T1DM and T1DM males), copper (positively, in
T1DM males and in both sexes together in T2DM),
selenium (positively, in both sexes together in T1DM
and T2DM, and T2DM females) and with zinc/copper
ratio (negatively, in both sexes together in T1DM and
T2DM). This study shows that plasma magnesium
concentration is altered to the highest degree in T1DM,
while in T2DM, plasma selenium and copper concen-
trations are significantly affected. This work increases
our understanding of how T1DM and T2DM affects
plasma metal concentrations and may have future
implications for diabetes management.
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Introduction
Diabetes is mainly divided into two types. In type-I
diabetes (T1DM), the b-cells of the islets of Langer-
hans in the pancreas responsible for producing insulin
are lost, typically from an attack from the immune
system, causing an insulin deficiency in the body. In
type-II diabetes (T2DM), cells become resistant to
insulin signalling, failing to respond to it sufficiently.
This is combined with either normal or increased
insulin levels but can also develop into insulin
deficiency through a relative loss of the insulin storage
function of b-cells. Glucose levels in the body are
important, as directly or indirectly they regulate many
physiological processes, including glucose, glycogen
metabolism. It also acts to control food intake (satiety)
and maintaining long-term body weight but also
regulates inflammation, vasodilatation and basic cell
growth and replication. Thus, mishandling of glucose
has wide-ranging consequences in the body. Among
them is an alteration in the total plasma concentrations
of micronutrients including somemetal ions (Kaur and
Henry 2014). This is thought to be caused by
numerous factors, which include increased fluid loss
from the body, an increased demand for micronutri-
ents due to altered protein metabolism as well as
defective metal transport due to oxidative stress (Kaur
and Henry 2014; Maret 2017).
Variations in plasma metal concentrations in dia-
betes have been extensively studied in different
populations. However there is a great heterogeneity
in the data, with both higher and lower levels of the
same metals having been reported (e.g. zinc and
selenium) (Wang et al. 2016; Sanjeevi et al. 2018).
Several meta-analyses have been performed in order
to find a consensus on whether levels of some metals
are higher or lower in diabetes (Wang et al. 2016;
Sanjeevi et al. 2018). Analyses of quartiles of
selenium concentrations yielded interesting results,
with both the lowest and highest quartiles being
associated with T2DM (Wang et al. 2016). Sex
differences have also been shown to be of some
importance with higher levels of copper reported in
females with T1DM but not males (Ruiz et al. 1998).
In addition, glycated haemoglobin (HbA1c) level as an
indication of diabetes management was found to
correlate with several plasma metal concentrations,
including zinc, copper and magnesium and also to the
zinc/copper ratio (Naka et al. 2013; Ramadass et al.
2015; Atari-Hajipirloo et al. 2016).
Here, we have examined the total plasma concen-
trations of zinc, copper, magnesium and selenium in
patients with T1DM and T2DM and in controls,
assessing the correlation between quartiles of metal
cations concentrations and diabetes, as well as the
influence of sex and diabetes management through
blood HbA1c levels. Plasma metal concentrations and
potential sex differences in those concentrations have
not been thoroughly examined both in T1DM and in
T2DM in the same study before. The results indicate
that magnesium deficiency is particularly important in
T1DM while elevated copper and selenium deficiency
in females are more important in T2DM. A better
understanding of those effects could lead to a better
understanding of metal micronutrient handling and to
better management and treatment of T1DM and
T2DM.
Methods
Samples collection and treatment
A total of 45 patients with T1DM, 54 patients with
T2DM and 62 controls were recruited from Leeds
Teaching Hospital Trust. Plasma samples from sub-
jects with either T1DM or T2DM and controls were
collected following approval by the local Research
Ethics Committee in Leeds and after obtaining written
informed consent. For all subjects, baseline fasting
blood samples were collected in lithium heparin
coated tubes. Plasma was then separated within 2 h
of collection by centrifugation at 24009g for 20 min
at 4 C. Samples were snap frozen in liquid nitrogen
and stored at - 40 C until analysis.
Inductively-coupled plasma-mass spectrometry
(ICP-MS)
Single element stock solutions (Centripure, Merck,
UK) traceable to the United States National Institute of
Standards and Technology (NIST) were used for
calibration standards and internal standards. All
calibration standards were prepared using a solution
of 2% v/v butan-1-ol (Sigma Aldrich, USA), 0.05%
w/v EDTA (Sigma Aldrich), 0.05% v/v Triton-X-100
(Sigma Aldrich), 1% v/v ammonia (Romil, UK) in
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18.2 Mohm reverse osmosis deionised water (Elga
Maxima High Wicombe, UK). Lithium heparin
plasma samples were diluted 1 in 10 with the same
solution used to prepare calibration standards with
25 ppb germanium. ClinChek 1 & 2 (RECIPE,
Germany) and SeronormTM 1 (SERO, Norway) human
serum certified reference materials were used to
demonstrate accuracy. ClinChek1 and 2 are materi-
als with consensus values while SeronormTM is
traceable to a National Institute of Standard Technol-
ogy (NIST) certified reference material.
Copper, zinc, selenium and magnesium analyses
were performed simultaneously using an Agilent 7900
ORS-ICP-MS (Agilent Technologies, Santa Clara,
California, USA). The instrument was controlled
using Mass Hunter software (version 4.1, Agilent
Technologies). Argon was used to form the plasma
(CryoServices Ltd, purirty: 99.9%). Polyatomic inter-
ferences for copper, zinc and magnesium were
removed through collision induced dissociation and
kinetic energy discrimination using helium gas (Air
Products and Chemicals, Inc, purity 99.9%). Poly-
atomic and doubly charged interferences for selenium
were removed using a charge exchange reaction by
using the collision cell with hydrogen. The concen-
tration of all elements was measured three times
within a single run using the central 0.05 m/z of the
peak. The ICP-MS was equipped with an CETAC
ASX-500 series autosampler (Teledyne CETAC,
Omaha, USA), an Integrated Sample Introduction
System and Discrete Sampler—3 (ISIS-DS, Agilent
Technologies) and a G32992A re-circulating chiller
(Polyscience, Illinois, USA). The ISIS-DS was fitted
with a Quartz Scott-Type, Double-Pass Spray Cham-
ber (Agilent Technologies), a glass micromist nebu-
liser (Agilent Technologies) and a sample loop. The
sample loop was prepared in-house using 0.8 mm
internal diameter and PTFE sample tubing (Agilent
Technologies). A quartz torch with 2.5 mm internal
diameter was used (Agilent Technologies). Nickel
sampling and skimmer cones were used at all times
(Agilent Technologies). All instrument parameters
were optimised daily by performing an auto-tune
while aspirating a tuning solution containing 10 ppb
lithium, yttrium, cobalt, cerium and thallium. Typical
instrument parameters are shown in Table 1. Three
certified reference materials (Seronorm 1 and Clin-
Check 1 and 2) with assigned values and ranges were
used to demonstrate the accuracy of the method used
to determine the concentrations of Mg, Cu, Zn and Se
in human plasma (Table 2). The mean for all measur-
ands were within the assigned range for all materials
and had satisfactory recoveries ranging between 96.4
and 107%. The precision of the method, represented
by coefficient of variation, was also satisfactory with
values less than or equal to 3%. All metal concentra-
tions in plasma were compared to the glycated
haemoglobin concentrations which were measured in
the samples as a routine test.
Statistical analysis and representation
Data are presented as mean ± standard error of the
mean (SEM). Graphs were generated and statistical
analysis was performed using Prism 7.0 (GraphPad
Software, La Jolla, CA). Differences between groups
were analysed using multiple Student’s t-tests or
analysis of variance, while correlations between linear
variants were analysed with Pearson’s correlation. The
data was also separated into quartiles and odd ratios
were calculated. Significance threshold was set at
p B 0.05.
Results and discussion
Total plasma zinc, copper, magnesium, selenium
concentrations and zinc/copper ratios in T1DM
and T2DM
ICP-MS was used to determine the total plasma
concentrations of zinc, copper, magnesium and sele-
nium in subjects with T1DM or T2DM and in their
respective age-matched controls. The zinc/copper
ratio was also calculated in all samples. Table 3
summarises the demographic characteristics of our
population as well as the mean plasma HbA1c and
metal concentrations values in each group. As
expected, t-tests indicate that subjects with T1DM or
T2DM have higher plasma concentrations of HbA1c
than controls. Both diabetes groups also had higher
mean BMI values than controls, while the T2DM
group also has a higher percentage of male subject
than the controls. Mean plasma zinc, copper and
selenium concentrations were not significantly altered
in subjects with either T1DM or T2DM compared to
controls. Whereas the mean plasma magnesium con-
centration was significantly lower in subjects with
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T1DM than in controls but not with T2DM, while the
plasma zinc/copper ratio was significantly higher in
T2DM subjects than in controls, but this was not the
case in T1DM.
The data from each of the two diabetes groups,
(T1DM and T2DM subjects; each with their respec-
tive age-matched controls) were split into quartiles for
each metal, defined as four groups delimited by 25%,
median and 75% of highest values in each of the
groups. The odd ratios (ORs) of a subject in a specific
quartile having diabetes were calculated (Table 4). No
significant difference in total plasma zinc concentra-
tions was observed between either the T1DM or the
T2DM groups and their age-matched controls. This is
contrary to two previous reports—a meta-analysis
accumulating 20,183 T2DM subjects and a study with
51 T1DM subjects both showing that zinc concentra-
tion is lower in diabetes (Li et al. 2018; Sanjeevi et al.
2018). Despite previous reports of both higher and
lower zinc concentrations being associated with
T2DM, no significance could be gained by examining
quartiles of zinc concentrations (Sanjeevi et al. 2018).
In T2DM, the ORs of having diabetes in the second
(Q2), third (Q3) and fourth (Q4) copper quartile
groups were respectively 0.031 [95% confidence
interval (CI) 0.080–1.275, p[ 0.05], 0.193 (95% CI
0.051–0.966, p\ 0.05) and 0.276 (95% CI
0.070–1.154, p[ 0.05) compared with the first (Q1)
quartile group. The absence of a clear difference
between T2DM subjects and controls (with only Q3
being significantly associated with the absence of
diabetes) can be explained by the mean plasma copper
concentration being very low in our T2DM group and
high in our age-matched controls, almost enough to be
significantly higher in the controls (p = 0.0698),
whereas a meta-analysis involving 20,183 T2DM
Table 1 ICP-MS
instrument parameters
Parameter Setting
Isotopes monitored (m/z) Cu 63, Zn 66, Se 78 and Mg 24
RF power (W) 1550
RF matching 1.70
Sampling depth (mm) 10
Carrier gas (L/min) 1.05
Make up gas L/min) 0.0
Spray chamber temperature (C) 2
He octopole reaction system flow (mL/min) 5.0
Nebuliser pump (rps) 0.1
Table 2 Accuracy of the ICP-MS method and details of the concentration of trace elements in each material (coefficient of variation
and recovery)
Measurand Specimen Assigned value Range Mean CV (%) Recovery (%)
Plasma Mg (mM) ClinCheck 1 0.64 0.58–0.71 0.62 1.8 97.6
ClinCheck 2 1.21 1.09–1.33 1.17 1.5 96.4
Plasma Cu (lM) Seronorm1 17.1 15.7–18.7 17.0 1.8 99.6
ClinCheck 1 10.9 8.7–13.1 10.7 1.3 97.8
ClinCheck 2 19.1 15.4–23.0 19.0 1.4 98.8
Plasma Zn (lM) Seronorm1 16.8 14.6–19.0 17.8 3.0 107
ClinCheck 1 17.7 14.2–21.3 17.6 0.8 99.2
ClinCheck 2 23.2 18.8–28.3 24.2 1.3 104.2
Plasma Se (lM) Seronorm1 1.10 0.96–1.25 1.09 0.8 98.8
ClinCheck 1 1.03 0.82–1.24 1.06 0.7 103
ClinCheck 2 1.52 1.22–1.82 1.57 1.2 104
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individuals has shown that plasma copper is higher in
T2DM (Sanjeevi et al. 2018). There were no differ-
ences in plasma copper concentrations between quar-
tiles in the T1DM group, contrary to a previous study
(Ruiz et al. 1998). The ORs of having T1DM in the
Q2, Q3, Q4 magnesium groups were 0.176 (95% CI
0.058–0.628, p\ 0.01), 0.1173 (95% CI 0.036–0.432,
p\ 0.01) and, 0.086 (95% CI 0.028–0.325,
p\ 0.001) compared with the Q1 group. Thus,
T1DM is associated with lower plasma magnesium
concentrations (Q2–Q4), as supported by a previous
study (Brown et al. 1999). In T2DM, no differences in
magnesium concentration were observed between
quartiles. This is despite a meta-analysis involving
286,668 T2DM subjects having found an association
between low dietary magnesium levels and T2DM,
while another study following 12,128 non-diabetic
subjects over 6 years reported an inverse relationship
between serum magnesium concentrations and inci-
dence of T2DM amongst white (but not black)
participants (Kao et al. 1999; Larsson and Wolk
2007). For plasma selenium concentrations, the ORs
of having T2DM in the Q2, Q3 and Q4 selenium
groups were respectively 0.850 (95% CI 0.221–3.292,
p[ 0.05), 0.560 (95% CI 0.152–2.484, p[ 0.05) and
0.100 (95% CI 0.017–0.682, p\ 0.01) compared with
Table 3 Demographic characteristics of the studied population and mean plasma HbA1c and metal concentrations in each group
Characteristics T1DM
subjects
(n = 45)
T1DM age-
matched
controls
(n = 47)
t test between
T1DM and age-
matched controls
T2DM
subjects
(n = 54)
T2DM age-
matched
controls
(n = 18)
t-test between
T2DM and age-
matched controls
Age
(years ± SD)
26.3 ± 6.8 24.3 ± 6.2 ns 61.1 ± 7.6 57.1 ± 8.9 ns
Males, n (%) 26 (58) 24 (51) ns 47 (87) 9 (50) ***
BMI
BMI (kg/
m2 ± SD)
24.6 ± 3.6 23.0 ± 3.0 * 32.6 ± 5.3 25.0 ± 3.2 ***
n (%) for
BMI\ 25
24 (53) 38 (81) – 2 (4) 10 (59) –
n (%) for BMI
25 to\ 30
18 (40) 8 (17) – 17 (31) 6 (35) –
n (%) for
BMI C 30
3 (7) 1 (2) – 35 (65) 1 (6) –
HbA1c conc.
mean
(mM ± SD)
69.8 ± 18.0 33.5 ± 0.7 ** 72.4 ± 22.8 37.6 ± 4.2 ***
Zinc conc.
mean
(lM ± SD)
12.80 ± 1.50 13.50 ± 2.30 ns 12.70 ± 1.40 12.38 ± 1.69 ns
Copper conc.
mean
(lM ± SD)
17.56 ± 6.60 16.26 ± 5.50 ns 15.49 ± 2.78 17.30 ± 4.70 ns
Magnesium
conc. mean
(mM ± SD)
0.747 ± 0.057 0.806 ± 0.054 *** 0.738 ± 0.075 0.765 ± 0.115 ns
Selenium conc.
mean
(lM ± SD)
1.147 ± 0.145 1.129 ± 0.136 ns 1.142 ± 0.188 1.222 ± 0.261 ns
Zinc/copper
(ratio ± SD)
0.813 ± 0.273 0.886 ± 0.246 ns 0.841 ± 0.152 0.751 ± 0.187 *
Significance is indicated as *p\ 0.05, **p\ 0.01 and ***p\ 0.001
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the Q1 group. Thus, low selenium concentrations were
linked with T2DM. The fact that subjects in Q4 did not
associate with T2DM is contrary to the findings of
previously published meta-analysis based on 13,460
T2DM patients, where both Q1 and Q4 were associ-
ated with T2DM (Wang et al. 2016). No differences in
plasma selenium concentrations were observed
between quartiles in T1DM, although a previous study
indicated that lower plasma selenium concentrations
have been found in T1DM (Ruiz et al. 1998). Here we
were unable to see any differences between zinc/cop-
per ratio quartiles in either T1DM or T2DM, contrary
to the higher mean ratios we measured in T2DM.
Some previous publications also indicated that lower
plasma zinc/copper ratios have been observed in
T1DM (Lin et al. 2014) and in T2DM (Atari-
Hajipirloo et al. 2016). The failure to detect some of
these previously reported relationships in our study
may be due to the number of subjects (and the resultant
effect on statistical power). Thus larger cohort studies
enable relatively subtle differences in plasma metal
concentrations to be observed between individuals
with diabetes and controls. However, those differences
may not be as relevant as those that can be detected in
smaller cohorts.
Differences in plasma metal concentrations
between males and females with T1DM or T2DM
The influence of the sex of the subjects on plasma
metal concentrations between the various groups was
examined (Table 5). In our age-matched controls for
the T1DM group, males had significantly higher zinc
concentrations and lower copper concentrations than
females, while in the T1DM group males had signif-
icantly higher zinc and magnesium concentrations and
lower copper concentrations than females. The T2DM
group was harder to study as there were few females in
the group. However, copper concentrations were
significantly lower and the zinc/copper ratio higher
in males than in females. The T1DM and T2DM
groups were then compared with their respective age-
matched controls. Magnesium concentrations were
lower in males and females with T1DM than in the
respective controls, while only males with T2DM had
a lower magnesium concentration than their respective
controls. In addition, the zinc/copper ratio was higher
in males with T2DM than in the male controls.
The plasma metal concentration quartile groups
described above were split according to sex (Table 6).
The ORs of having T1DM in the Q2, Q3 and Q4
female magnesium quartile groups were respectively
0.000 (95% CI 0–0.480, p\ 0.01), 0.059 (95% CI
0.005–0.482, p\ 0.05) and 0.033 (95% CI
0.003–0.287, p\ 0.001) compared to the Q1 group.
There were no differences between magnesium quar-
tiles in T1DMmales despite a lower mean having been
observed compared to male controls. To our knowl-
edge, no sex differences in mean plasma magnesium
concentrations in T1DM subjects have been reported
before. No significance differences in male copper
quartiles or in female copper quartiles were observed
in T1DM. This is contrary to a report, which found that
plasma copper concentrations were higher in females
with T1DM than in females controls but that this was
not the case in males (Ruiz et al. 1998). However
another study (with only 18 individuals and both
T1DM and T2DM analysed together) reported the
absence of any difference in plasma copper concen-
tration between males and females with diabetes
(Terres-Martos et al. 1998). In addition, no significant
differences in male or in female zinc or zinc/copper
quartiles were identified in T1DM.
The low number of females among our T2DM
cohort made accurate comparison between the sexes
more difficult to perform and no statistically signifi-
cant differences were found with any metal when
examining female subjects in the quartiles. However,
when looking at males only the copper Q3, magnesium
Q4 and selenium Q4 groups were associated with the
absence of T2DM. The ORs of having T2DM in the
Q2, Q3 and Q4 male copper quartile groups were
respectively 0.167 (95% CI 0.011–1.649, p[ 0.05),
0.074 (95% CI 0.006–0.625, p\ 0.05) and 0.074
(95% CI 0.005–0.842, p[ 0.05) compared to the Q1
group. In a meta-analysis of copper concentrations in
T2DM, no sex differences were observed (Sanjeevi
et al. 2018). The ORs of having T2DM in the Q2, Q3
and Q4 male magnesium quartile groups were respec-
tively 0.9444 (95% CI 0.04734–18.9, p[ 0.05),
0.1944 (95% CI 0.01285–2, p[ 0.05) and 0.056
(95% CI 0.004–0.582, p\ 0.05) compared to the Q1
group. Contrary to this, a previous study has found that
females with T2DM were more likely to have lower
magnesium concentrations than males (Kao et al.
1999). The ORs of having T2DM in the Q2, Q3 and Q4
male selenium quartile groups were respectively for
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selenium 0.938 (95% CI 0.047–18.89, p[ 0.05),
0.219 (95% CI 0.017–1.703, p[ 0.05), 0.031 (95%
CI 0.002–0.601, p\ 0.05) compared to the Q1 group.
Association between T2DM and selenium concentra-
tions (too low or too high) in males but not females
have been reported before (Bleys et al. 2007; Laclaus-
tra et al. 2009; Akbaraly et al. 2010).
Relationship between plasma metal concentrations
and HbA1c concentration
Relationships between HbA1c concentration, as a
proxy for glycemic control, and metal concentrations
in subjects with T1DM (Fig. 1) or T2DM (Fig. 2)
were examined. Plasma zinc concentration did not
correlate with HbA1c concentration in either T1DM or
T2DM, which is in accord with a previous finding in
T1DM but contrary to a previous publication that has
found a negative correlation (Luo et al. 2015; Lin et al.
2016). In T1DM, plasma copper concentration posi-
tively correlated with HbA1c concentration in males
(p = 0.042, Fig. 1e) but not with females or with both
sexes together. In T2DM, the plasma copper concen-
tration correlated with HbA1c concentration only
when considering both sexes together (p = 0.003,
Fig. 2d) but not in males or females only. Previous
studies have found that plasma copper concentration
do not correlate with HbA1c concentration in T1DM
but positively correlates in T2DM (Ruiz et al. 1998;
Atari-Hajipirloo et al. 2016). Plasma magnesium
concentration negatively correlated with HbA1c con-
centration in T1DM when looking at both sexesT
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cFig. 1 Relationship between HbA1c concentration and plasma
zinc, copper, magnesium and selenium concentrations as well as
zinc/copper ratio in all T1DM subjects and male and female
T1DM subjects. a–c HbA1c concentration vs zinc concentra-
tion, d–f HbA1c concentration vs copper concentration, g–
i HbA1c concentration vs magnesium concentration, j–l HbA1c
concentration vs selenium concentration and m–o HbA1c
concentration vs zinc/copper ratio. a, d, g, j, m both sexes
together, b, e, h, k, n male subjects and c, f, i, l, o female
subjects. Black circles were used for the data that were
correlated to HbA1c concentration, while white circles were
used when the relationship was not significant. HbA1c
concentration was positively correlated with plasma copper
concentration in males (p = 0.0418) and with plasma selenium
concentration in both sexes together (p = 0.0311), while it was
negatively correlated with plasma magnesium concentration in
both sexes together (p = 0.0040) and in males (p = 0.0067) and
with the zinc/copper ratio in both sexes together (p = 0.0258)
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together (p = 0.004, Fig. 1g) and in males (p = 0.007,
Fig. 1h), but not in females and it did not correlate
with HbA1c concentration in T2DM. The lack of an
observable relationship between plasma magnesium
concentration and HbA1c concentration in females
with T1DM is surprising considering that magnesium
concentration was lower in females with T1DM
compared to males with T1DM (while no difference
between the sexes could be seen in controls). Previous
studies have shown that HbA1c levels correlate with
magnesium excretion in females but not males (Brown
et al. 1999; Lin and Huang 2015). A negative
correlation between plasma magnesium concentration
and HbA1c concentration has also been reported in
T2DM (Ramadass et al. 2015). Plasma selenium
concentration correlated negatively with HbA1c in
T1DM when looking at both sexes together
(p = 0.031, Fig. 1j), as in a previous study (Ruiz
et al. 1998), but there was no correlation when looking
individually at males or females. In T2DM, plasma
selenium concentration was correlated with HbA1c
concentration when looking at both sexes together
(p = 0.039, Fig. 2j) and in females (p = 0.015,
Fig. 2l), contrary to a previous study that found a
negative correlation with dysregulation of glucose and
selenium concentration in males but not in females
(Akbaraly et al. 2010). The plasma zinc/copper ratio
was negatively correlated with HbA1c in T1DM and
T2DM when looking at both sexes together
(p = 0.0258, Fig. 1m and p = 0.0428, Fig. 2m respec-
tively) but not in males or females only. In previous
publications, the zinc/copper ratio was also negatively
correlated in T1DM and T2DM (Lin et al. 2014; Atari-
Hajipirloo et al. 2016). Correlation of HbA1c concen-
tration with total plasma metal concentrations could
potentially be explained by glycation or oxidation-
associated modifications of metal ion transport pro-
teins (Abdelmagid et al. 2015), formation of glyco-
cholate (anion of the bile acid glycholic acid) that can
complex and excrete metals in bile (Atari-Hajipirloo
et al. 2016) or abnormal insulin signalling leading to
dysregulated metal homeostasis (McNair et al. 1982;
Gommers et al. 2016).
Implications for dysregulated metal homeostasis
in diabetes
Changes in total plasma metal concentrations in
subjects with diabetes have the potential to negatively
affect metabolic processes in the body. Low magne-
sium concentrations have been associated with an
increased incidence of T1DM and T2DM and poor
glycaemic control (Lin and Huang 2015; Ramadass
et al. 2015). This may be due to the fact that
magnesium ions (Mg2?) are an essential cofactor in
several processes. Mg2? increases the affinity of
insulin receptors for ATP and is thus essential for
their auto-phosphorylation and tyrosine kinase activ-
ity, which results in Mg2? sensitising cells to insulin
(Guerrero-Romero and Rodriguez-Moran 2011; Gom-
mers et al. 2016; Al Alawi et al. 2018). Thus
chronically low Mg2? concentrations can lead to
insulin resistance (Guerrero-Romero and Rodriguez-
Moran 2011; Gommers et al. 2016; Al Alawi et al.
2018). Furthermore, Mg2? can also block the entry of
Ca2? into adipocytes through the L-type calcium
channel. Therefore, when Mg2? concentrations are
insufficient, increased Ca2? entry in adipocyte leads to
inflammation, oxidative stress and increase insulin
resistance (Nielsen et al. 2007; Gommers et al. 2016;
Al Alawi et al. 2018). Mg2? is also involved in the
transport of glucose across membranes, it is a cofactor
of several enzymes essential for carbohydrate oxida-
tion (e.g. phosphotransferases and phosphohydrolases
such as ATPases) and also plays a role in the release of
insulin (Saris et al. 2000; Al Alawi et al. 2018). On the
other hand, insulin decreases tubular reabsorption of
Mg2? and so high insulin levels (as in T2DM) could
lead to reduced Mg2? concentrations (McNair et al.
1982; Gommers et al. 2016).
bFig. 2 Relationship between HbA1c concentration and plasma
zinc, copper, magnesium and selenium concentrations as well as
zinc/copper ratio in all T2DM subjects and male and female
T2DM subjects. a–c HbA1c concentration vs zinc concentra-
tion, d–f HbA1c concentration vs copper concentration, g–
i HbA1c concentration vs magnesium concentration, j–l HbA1c
concentration vs selenium concentration and m–o HbA1c
concentration vs zinc/copper ratio. a, d, g, j, m both sexes
together, b, e, h, k, n male subjects and c, f, i, l, o female
subjects. Black circles were used for the data that were
correlated to HbA1c concentration, while white circles were
used when the relationship was not significant. HbA1c
concentration was positively correlated with plasma copper
concentration in both sexes together (p = 0.0034) and with
plasma selenium concentration in both sexes together
(p = 0.0394) and in females (p = 0.0150), while it was
negatively correlated with the zinc/copper ratio in both sexes
together (p = 0.0428)
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Selenium is mostly found in selenoproteins (as
selenomethionine), of which many are important anti-
oxidants (Roman et al. 2014). Therefore, high plasma
concentrations of selenium may be due to oxidative
stress mobilising high levels of selenoproteins. For
example, the plasma concentration of selenoprotein P
is known to be higher in T2DM subjects, a disease
state associate with high levels of oxidative stress, and
to be associated with insulin resistance (Misu et al.
2010; Ogawa-Wong et al. 2016). However, expression
of plasma glutathione peroxidase (another selenopro-
tein) as well as serum albumin (which transports
selenomethionine) are reduced in diabetes (Roman
et al. 2010). Expression of selenoprotein P is known to
be reduced during inflammation (Nichol et al. 1998;
Hesse-Bahr et al. 2000). Thus blood levels of selenium
decrease during systemic inflammatory responses,
which occur in T2DM (Wang et al. 2013). It has been
hypothesised that the stages of the disease (impaired
glucose tolerance or well-established T2DM) and the
associated level of oxidative stress influences plasma
selenium concentration (Rayman and Stranges 2013).
Zinc participates in the synthesis, storage and
release of insulin. Notably, zinc is present in secretory
vesicles within b-cells of the pancreas where it
participates in the crystallisation/storage of insulin
and is thus released alongside insulin into the plasma
(Scott 1934; Chabosseau and Rutter 2016). Deficiency
of zinc disrupts insulin homeostasis, resulting in a
reduction of insulin secretion by b cells (Fung et al.
2015). Zinc also stimulates lipogenesis and glucose
uptake and reduced lipolysis in adipocytes (Coulston
and Dandona 1980; Nishide et al. 2008). As zinc and
copper homeostasis are closely linked, notably through
competition during intestinal absorption and through
shared transporter proteins such as serum albumin, a
deficiency in one can affect the other (Osredkar and
Sustar 2011). For example, zinc over-supplementation
can lead to copper deficiency (Duncan et al. 2015).
Impairedmetabolism of zinc and copper are associated
with a higher sensitivity to oxidative damage, as both
zinc and copper are needed for the activity of the
antioxidant enzyme superoxide dismutase, whose
activity is reduced in T2DM (Sundaram et al. 1996).
Thus, changes in the ratio of zinc/copper will affect
enzyme catalysis and potentially further increase
levels of free radicals, which are already increased in
diabetes (Giacco and Brownlee 2010). In addition,
copper is released from superoxide dismutase at high
glucose concentrations due to fragmentation of the
protein during glycation (Ookawara et al. 1992).
Elevated copper levels in T2DM correlate with
formation of reactive oxygen species (Masad et al.
2007). Insulin also reduces copper concentration in the
liver through the regulation of at least one copper-
transporting ATPase, ATP7B (Hilario-Souza et al.
2016). A reduction in insulin concentrations may thus
result in an accumulation of copper in the liver.
Deficiency in magnesium, selenium and zinc have
been shown to increase the risks of developing
complicates associated with diabetes. Therefore, the
effect of supplementation of these metals has been
assessed. Magnesium supplementation was found to
both improve diabetes management and to reduce the
development of T2DM in individuals at risk (Ro-
driguez-Moran and Guerrero-Romero 2003; Hruby
et al. 2014; Guerrero-Romero et al. 2015). Zinc
supplementation has been shown to improve insulin
and glucose levels in diabetes subjects and decrease
the risk of developing T2DM (Jayawardena et al.
2012; Islam et al. 2016; Ranasinghe et al. 2018).
However, selenium supplementation was not found to
improve the risk of developing T2DM or the risk of
developing complications in individuals with diabetes
(Ogawa-Wong et al. 2016). This could be because the
association between selenium concentrations and
diabetes is not linear and that only individuals with
selenium deficiency would benefit from supplementa-
tion, while individuals with sufficient selenium could
increase their risk of developing T2DM if given an
excess of this metal (Ogawa-Wong et al. 2016).
Another explanation may be that the form of selenium
used for supplementation in some studies offer
variable bioavailability (Ogawa-Wong et al. 2016).
Conclusion
In conclusion, the study reported here is the first to
examine zinc, copper, magnesium, selenium and
HbA1c concentrations and sex-specific differences
together in both T1DM, T2DM and controls. The
homeostatic control of circulatory metal concentra-
tions, in particular zinc, copper, magnesium and
selenium, is essential for insulin regulation and energy
metabolism. If plasmametal concentrations are altered
in an individual with diabetes, themanagement of their
condition will be more complex and they are more
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likely to develop complications. In addition, plasma
metal concentrations are also influenced by insulin and
glucose plasma levels. Thus, if those are not properly
controlled, plasma metal concentrations are likely to
become further dysregulated. Here we show that
plasma magnesium concentration is altered to the
highest degree in T1DM. In T2DM, plasma selenium
and copper concentrations were significantly affected.
This work increases our understanding of T1DM and
T2DM pathogenesis and may have future implications
for the management of diabetes.
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